- Home
- CNTB vs TACT Comparison
CNTB vs TACT Comparison
Compare CNTB & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- TACT
- Stock Information
- Founded
- CNTB 2012
- TACT 1996
- Country
- CNTB United States
- TACT United States
- Employees
- CNTB N/A
- TACT N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- TACT Computer peripheral equipment
- Sector
- CNTB Health Care
- TACT Technology
- Exchange
- CNTB Nasdaq
- TACT Nasdaq
- Market Cap
- CNTB 43.2M
- TACT 35.6M
- IPO Year
- CNTB 2021
- TACT 1996
- Fundamental
- Price
- CNTB $0.79
- TACT $3.66
- Analyst Decision
- CNTB Strong Buy
- TACT Strong Buy
- Analyst Count
- CNTB 1
- TACT 1
- Target Price
- CNTB $8.00
- TACT $5.00
- AVG Volume (30 Days)
- CNTB 68.9K
- TACT 23.5K
- Earning Date
- CNTB 05-15-2025
- TACT 05-13-2025
- Dividend Yield
- CNTB N/A
- TACT N/A
- EPS Growth
- CNTB N/A
- TACT N/A
- EPS
- CNTB N/A
- TACT N/A
- Revenue
- CNTB $26,033,000.00
- TACT $45,750,000.00
- Revenue This Year
- CNTB N/A
- TACT $14.81
- Revenue Next Year
- CNTB N/A
- TACT N/A
- P/E Ratio
- CNTB N/A
- TACT N/A
- Revenue Growth
- CNTB N/A
- TACT N/A
- 52 Week Low
- CNTB $0.51
- TACT $3.12
- 52 Week High
- CNTB $2.07
- TACT $5.11
- Technical
- Relative Strength Index (RSI)
- CNTB 50.92
- TACT 49.91
- Support Level
- CNTB $0.73
- TACT $3.45
- Resistance Level
- CNTB $0.85
- TACT $3.89
- Average True Range (ATR)
- CNTB 0.06
- TACT 0.24
- MACD
- CNTB -0.00
- TACT -0.01
- Stochastic Oscillator
- CNTB 51.07
- TACT 37.66
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.